Sort
10,766 grants matching “checkpoint inhibitor”
Mechanisms of Nucleic Acid Repair Enzymes
$0Environmental Health Sciences · Z01 · FY2004 · ES
Double-strand Breaks And Untargeted Dna Metabolic Events
$0Environmental Health Sciences · Z01 · FY2005 · ES
Mechanisms of Nucleic Acid Enzymes - Pol Beta and Mammal
$0Environmental Health Sciences · Z01 · FY2005 · ES
Cellular Biology Of Host/parasite Interactions
$0Niaid Extramural Activities · Z01 · FY2005 · AI
DNA Repair, Cell Cycle Checkpoints and Apoptosis as Targ
$0Basic Sciences · Z01 · FY2004 · BC
Tumor Suppressor Protein, p53
$0Basic Sciences · Z01 · FY2002 · BC
DNA Topoisomerases as Target of Action of Anticancer Dru
$0Basic Sciences · Z01 · FY2004 · BC
Mechanisms of G2/M cell cycle checkpoint controls
$0Basic Sciences · Z01 · FY2002 · BC
DNA Topoisomerases as Target of Action of Anticancer Dru
$0Basic Sciences · Z01 · FY2002 · BC
Studies of Histone Functions in Chromatin;H2AX and DNA
$0Basic Sciences · Z01 · FY2004 · BC
Development of Novel Therapeutic Strategies for Thoracic
$0Basic Sciences · Z01 · FY2004 · BC
Inhibition of p53 Tumor Suppressor Function by HTLV-I
$0Basic Sciences · Z01 · FY2005 · BC
Targeting Integrins in Lung Cancer
$0Tianhong Li · Va Northern California Health Care Sys · I01 · FY2023 · VA
Regulation of cutaneous immune function and anti-tumor immune responses by PPARgamma-mediated transrepressive signaling
$0Raymond L Konger · Rlr Va Medical Center · I01 · FY2017 · VA
Type I Interferon Regulation of PD-L1 Expression and Function in MDSCs
$0Kebin Liu · Charlie Norwood Va Medical Center · I01 · FY2022 · VA
Agnostic Immunization by Immunogenic Cell Death
$0John M. Jessup · U.S. Dept/Vets Affairs Medical Center · I01 · FY2021 · VA
Stratification of Pancreatic Cancer Subpopulations for Effective Immunotherapy
$0Qizhi C. Yao · Michael E Debakey Va Medical Center · I01 · FY2021 · VA
The role of eosinophils and oxidative stress in esophageal malignancy
$0Yash Choksi · Veterans Health Administration · IK2 · FY2021 · VA
Epigenetic Regulation of Immune Evasion in Bladder Cancer
$0Joshua James Meeks · Jesse Brown Va Medical Center · I01 · FY2021 · VA
Preclinical investigation of PI3K inhibition and immune checkpoint blockade combination therapy for treatment of Merkel cell carcinoma using humanized mouse models
$0Ling Gao · Veterans Health Administration · I01 · FY2021 · VA
A Phase 2 study of a Checkpoint Inhibitor in Men with Progressive Metastatic Castrate Resistant Prostate Cancer Characterized by a Mismatch Repair Deficiency or Biallelic CDK12 Inactivation
$0Matthew B Rettig · Va Greater Los Angeles Healthcare System · I01 · FY2021 · VA
Translational application of mouse models of melanoma brain metastases
$0Suzie Chen · Va New Jersey Health Care System · I01 · FY2021 · VA
BLR&D Merit Review Research Career Scientist (RCS) Award (IK6)
$0Ann Richmond · Veterans Health Administration · IK6 · FY2021 · VA
Improving Treatment Algorithms for Veterans with Oropharyngeal Cancer
$0Vlad C Sandulache · Michael E Debakey Va Medical Center · IK2 · FY2022 · VA
BLR&D Merit Review Research Career Scientist (RCS) Award (IK6)
$0Ann Richmond · Veterans Health Administration · IK6 · FY2022 · VA